We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGNA
1026
DELISTED
TEGNA Inc
TGNA
$499K 0.01%
30,555
-19,079
-38% -$323K
TARO
1027
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$498K 0.01%
+3,224
New +$471K
CXP
1028
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
$498K 0.01%
+21,219
New +$516K
RAX
1029
DELISTED
Rackspace Hosting Inc
RAX
$498K 0.01%
19,667
+10,899
+124% +$289K
AAWW
1030
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$498K 0.01%
+12,057
New +$489K
BMS
1031
DELISTED
Bemis
BMS
$497K 0.01%
11,111
+619
+6% +$27.7K
MDAS
1032
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
$497K 0.01%
16,076
-8,714
-35% -$242K
LILAK icon
1033
Liberty Latin America Class C
LILAK
$1.69B
$496K 0.01%
+13,469
New +$439K
VRTU
1034
DELISTED
Virtusa Corporation
VRTU
$495K 0.01%
+11,986
New +$603K
MSGN
1035
DELISTED
MSG Networks Inc.
MSGN
$494K 0.01%
+23,711
New +$482K
BID
1036
DELISTED
Sotheby's
BID
$494K 0.01%
19,184
+6,380
+50% +$193K
BOKF icon
1037
BOK Financial
BOKF
$8.58B
$492K 0.01%
+8,218
New +$538K
SBGI icon
1038
Sinclair Inc
SBGI
$1.02B
$491K 0.01%
+15,078
New +$480K
SSD icon
1039
Simpson Manufacturing
SSD
$7.79B
$490K 0.01%
14,364
+6,564
+84% +$238K
QLGC
1040
DELISTED
QLOGIC CORP
QLGC
$490K 0.01%
+40,257
New +$488K
SCTY
1041
CALL
DELISTED
SolarCity Corporation
SCTY
$490K 0.01%
9,600
LVS icon
1042
Las Vegas Sands
LVS
$32.2B
$489K 0.01%
11,165
-23,273
-68% -$1.06M
COLB icon
1043
Columbia Banking Systems
COLB
$8.71B
$488K 0.01%
+15,033
New +$502K
VGR
1044
DELISTED
Vector Group Ltd.
VGR
$488K 0.01%
+35,491
New +$496K
SCG
1045
DELISTED
Scana
SCG
$488K 0.01%
8,079
-16
-0.2% -$938
HT
1046
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$484K 0.01%
22,250
+10,099
+83% +$239K
RGC
1047
DELISTED
Regal Entertainment Group
RGC
$483K 0.01%
+25,600
New +$486K
WIBC
1048
DELISTED
WILSHIRE BANCORP INC
WIBC
$483K 0.01%
+41,779
New +$475K
CCOI icon
1049
Cogent Communications
CCOI
$635M
$480K 0.01%
13,843
-7,006
-34% -$226K
CMBT
1050
CMB.TECH NV
CMBT
$4.52B
$480K 0.01%
+35,005
New +$495K

Similar funds

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.